CytoVeris


OncoLux Inc. is dedicated to revolutionizing cancer surgery through innovative imaging and photodynamic therapy solutions. Their mission is to improve surgical outcomes by providing enhanced visualization of residual cancer and enabling targeted intraoperative treatments, ultimately aiming to reduce recurrence rates and preserve patient function.

Industries

health-care
health-diagnostics
medical
medical-device

Nr. of Employees

small (1-50)

CytoVeris

CIC Providence, 225 Dyer St., Flr 2, Providence, RI 02903


Patents

Method and system for detecting cancerous tissue and tumor margin using raman spectroscopy

US-12326404-B2

View Details

Digital mirror device based code-division multiplexed Raman optical mapping system for wide field imaging

US-12163891-B2

View Details

Method and system for identifying tissue type based on peak-fitted parameters in high-wavenumber Raman spectrum

US-12038383-B2

View Details

System and method for classification of tissue based on Raman and fluorescence in high-wavenumber Raman spectrum

US-11821841-B2

View Details

Raman spectroscopy-based optical matched filter system and method for using the same

US-11725984-B2

View Details

Raman spectroscopy based assay for both low and high abundant biomolecules in a biological fluid sample

US-11686684-B2

View Details
View All Patents

Products

Multispectral intraoperative imaging platform (specimen and surgical visualization)

An imaging platform that uses multispectral illumination and detection with AI-based classification to provide real-time visualization of tissue types and potential positive margins during surgery and on resected specimens.

Closed-loop PDT light dosimetry system for intraoperative therapy

A photonics system that measures light-tissue interaction in real time and automatically controls PDT light delivery via an optical applicator and fiber arrays to achieve prescribed dosimetry.

Integrated intraoperative theranostic system

A combined solution that integrates multispectral imaging-based margin detection with automated PDT delivery to enable intraoperative 'see-and-treat' workflows for residual cancer.


Services

Design and execution of specimen-level imaging studies with statistical cross-validation to evaluate imaging algorithm performance for breast, bladder, and prostate tissues.

Development, training, and validation of machine learning models using multispectral imaging datasets to identify malignant tissue and margins.

Engineering and integration of real-time PDT dosimetry systems including optical applicators, emitter/detector arrays, and closed-loop control algorithms for intraoperative therapy.

Collaborative programs with surgeons, pathologists, and academic institutions to support device evaluation, pilot clinical studies, and technology adoption pathways.

Establishment and maintenance of a QMS aligned to FDA Quality System Regulation and related quality activities including audits and training to support device development and commercialization.

Expertise Areas

  • Multispectral tissue imaging
  • AI-driven tissue classification
  • Photodynamic therapy dosimetry
  • Intraoperative surgical visualization
  • Show More (4)

Key Technologies

  • Multispectral autofluorescence imaging
  • Machine learning for image-based tissue classification
  • Real-time light dosimetry and closed-loop control
  • Optical surface applicator and fiber-optic emitter/detector arrays
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.